🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I Clinical Trial. Phase I studies are designed to determine...
Status
Terminated
Location
University of Maryland Greenebaum Cancer Center
Start Date
2010-04-27
Trial ID
NCT01110226
This study is a card Rayleigh bead single combined cisplatin treatment of a...
Status
Unknown
Location
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Start Date
2022-08-05
Trial ID
NCT05490485
Treatments Being Tested
This phase II trial studies the effect of bintrafusp alfa with pemetrexed a...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2021-06-30
Trial ID
NCT04971187
Treatments Being Tested
The investigators conducted a phase II, prospective, two-arm clinical study...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2023-05-25
Trial ID
NCT05821452
Treatments Being Tested
This is a study to look at whether the presence of circulating tumour DNA (...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2022-03-28
Trial ID
NCT04966663
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This study is designed to investigate whether adjuvant radiochemotherapy af...
Status
Withdrawn
Location
Kailiang Wu
Start Date
2023-12-01
Trial ID
NCT02633514
Treatments Being Tested
This is a prospective, multi-center, single arm study assessing the efficac...
Status
Unknown
Location
Henan Cancer Hospital
Start Date
2021-01-21
Trial ID
NCT04982549
Treatments Being Tested
Cisplatin and Etoposide is the standard of care in NEC originating from the...
Status
Unknown
Location
S.C. Oncologia - Policlinico
Start Date
2015-05
Trial ID
NCT02687958
Treatments Being Tested
The purpose of this study is to identify novel biomarkers of kidney injury ...
Status
Completed
Location
University of Chicago
Start Date
2009-09-22
Trial ID
NCT00984035
Treatments Being Tested